160 related articles for article (PubMed ID: 34655598)
1. NAAA inhibitor F96 attenuates BBB disruption and secondary injury after traumatic brain injury (TBI).
Li Y; Zhou P; Hu T; Ren J; Xu Y; Qiu Y; Lu C; Li Y
Eur J Pharmacol; 2021 Dec; 912():174561. PubMed ID: 34655598
[TBL] [Abstract][Full Text] [Related]
2. Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α.
Yang L; Li L; Chen L; Li Y; Chen H; Li Y; Ji G; Lin D; Liu Z; Qiu Y
Sci Rep; 2015 Aug; 5():13565. PubMed ID: 26310614
[TBL] [Abstract][Full Text] [Related]
3. Anti-Inflammatory Effects of Fucoxanthinol in LPS-Induced RAW264.7 Cells through the NAAA-PEA Pathway.
Jin W; Yang L; Yi Z; Fang H; Chen W; Hong Z; Zhang Y; Zhang G; Li L
Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32326173
[TBL] [Abstract][Full Text] [Related]
4.
Piomelli D; Scalvini L; Fotio Y; Lodola A; Spadoni G; Tarzia G; Mor M
J Med Chem; 2020 Jul; 63(14):7475-7490. PubMed ID: 32191459
[No Abstract] [Full Text] [Related]
5. Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation.
Solorzano C; Zhu C; Battista N; Astarita G; Lodola A; Rivara S; Mor M; Russo R; Maccarrone M; Antonietti F; Duranti A; Tontini A; Cuzzocrea S; Tarzia G; Piomelli D
Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20966-71. PubMed ID: 19926854
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models.
Sasso O; Moreno-Sanz G; Martucci C; Realini N; Dionisi M; Mengatto L; Duranti A; Tarozzo G; Tarzia G; Mor M; Bertorelli R; Reggiani A; Piomelli D
Pain; 2013 Mar; 154(3):350-360. PubMed ID: 23218523
[TBL] [Abstract][Full Text] [Related]
7. N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis.
Zhou P; Xiang L; Yang Y; Wu Y; Hu T; Liu X; Lin F; Xiu Y; Wu K; Lu C; Ren J; Qiu Y; Li Y
Pharmacol Res; 2019 Jul; 145():104264. PubMed ID: 31063807
[TBL] [Abstract][Full Text] [Related]
8. N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis.
Alhouayek M; Bottemanne P; Subramanian KV; Lambert DM; Makriyannis A; Cani PD; Muccioli GG
FASEB J; 2015 Feb; 29(2):650-61. PubMed ID: 25384424
[TBL] [Abstract][Full Text] [Related]
9. Palmitoylethanolamide (PEA) reduces postoperative adhesions after experimental strabismus surgery in rabbits by suppressing canonical and non-canonical TGFβ signaling through PPARα.
Li Y; Zhao S; Xu S; Li Y; Wang C; Ren J; Li F; Hu X; Lin K; Qiu Y; Xiu Y
Biochem Pharmacol; 2021 Feb; 184():114398. PubMed ID: 33385371
[TBL] [Abstract][Full Text] [Related]
10. Synergic Therapeutic Potential of PEA-Um Treatment and NAAA Enzyme Silencing In the Management of Neuroinflammation.
Casili G; Lanza M; Campolo M; Siracusa R; Paterniti I; Ardizzone A; Scuderi SA; Cuzzocrea S; Esposito E
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050589
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors.
Malamas MS; Farah SI; Lamani M; Pelekoudas DN; Perry NT; Rajarshi G; Miyabe CY; Chandrashekhar H; West J; Pavlopoulos S; Makriyannis A
Bioorg Med Chem; 2020 Jan; 28(1):115195. PubMed ID: 31761726
[TBL] [Abstract][Full Text] [Related]
12. Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215.
Li Y; Zhou P; Chen H; Chen Q; Kuang X; Lu C; Ren J; Qiu Y
Pharmacol Res; 2018 Jun; 132():7-14. PubMed ID: 29572189
[TBL] [Abstract][Full Text] [Related]
13. FGF21 Protects the Blood-Brain Barrier by Upregulating PPARγ via FGFR1/β-klotho after Traumatic Brain Injury.
Chen J; Hu J; Liu H; Xiong Y; Zou Y; Huang W; Shao M; Wu J; Yu L; Wang X; Wang X; Lin L
J Neurotrauma; 2018 Sep; 35(17):2091-2103. PubMed ID: 29648978
[TBL] [Abstract][Full Text] [Related]
14. Irisin Rescues Blood-Brain Barrier Permeability following Traumatic Brain Injury and Contributes to the Neuroprotection of Exercise in Traumatic Brain Injury.
Guo P; Jin Z; Wang J; Sang A; Wu H
Oxid Med Cell Longev; 2021; 2021():1118981. PubMed ID: 34697562
[TBL] [Abstract][Full Text] [Related]
15. Mdivi-1 alleviates blood-brain barrier disruption and cell death in experimental traumatic brain injury by mitigating autophagy dysfunction and mitophagy activation.
Wu Q; Gao C; Wang H; Zhang X; Li Q; Gu Z; Shi X; Cui Y; Wang T; Chen X; Wang X; Luo C; Tao L
Int J Biochem Cell Biol; 2018 Jan; 94():44-55. PubMed ID: 29174311
[TBL] [Abstract][Full Text] [Related]
16. Advances in the discovery of N-acylethanolamine acid amidase inhibitors.
Bandiera T; Ponzano S; Piomelli D
Pharmacol Res; 2014 Aug; 86():11-7. PubMed ID: 24798679
[TBL] [Abstract][Full Text] [Related]
17. N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats.
Fotio Y; Ciccocioppo R; Piomelli D
Psychopharmacology (Berl); 2021 Jan; 238(1):249-258. PubMed ID: 33037452
[TBL] [Abstract][Full Text] [Related]
18. N-Palmitoylethanolamine-Oxazoline as a New Therapeutic Strategy to Control Neuroinflammation: Neuroprotective Effects in Experimental Models of Spinal Cord and Brain Injury.
Impellizzeri D; Cordaro M; Bruschetta G; Siracusa R; Crupi R; Esposito E; Cuzzocrea S
J Neurotrauma; 2017 Sep; 34(18):2609-2623. PubMed ID: 28095731
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of metformin on traumatic brain injury in rats is associated with the AMP-activated protein kinase signaling pathway.
Rahimi S; Ferdowsi A; Siahposht-Khachaki A
Metab Brain Dis; 2020 Oct; 35(7):1135-1144. PubMed ID: 32621159
[TBL] [Abstract][Full Text] [Related]
20. Sesamin alleviates blood-brain barrier disruption in mice with experimental traumatic brain injury.
Liu YL; Xu ZM; Yang GY; Yang DX; Ding J; Chen H; Yuan F; Tian HL
Acta Pharmacol Sin; 2017 Nov; 38(11):1445-1455. PubMed ID: 28770828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
